AJO LP’s Rigel Pharmaceuticals RIGL Stock Holding History

AJO LP’s Portfolio RIGL Stock Details RIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-2,628	Closed	-$49K	–	659
2019 Q3	$49K	Buy	+2,628	New	+$54.3K	﹤0.01%	590

Other funds holding RIGL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

AJO LP's RIGL Position: Q4 2019 in Review

AJO LP sold out of Rigel Pharmaceuticals (RIGL) in Q4 2019, closing a stake of 2,628 shares — an estimated $49K sold.

AJO LP first reported a position in RIGL in Q3 2019 and held it in 1 quarter. The position peaked at $49K in Q3 2019. 136 funds tracked by Wall St. Rank hold RIGL as of Q4 2019.

AJO LP reported no remaining Rigel Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
AJO LP sold 2,628 Rigel Pharmaceuticals shares in Q4 2019, an estimated $49K.
AJO LP first reported a position in Rigel Pharmaceuticals in Q3 2019 and held it in 1 quarter.
AJO LP's Rigel Pharmaceuticals position peaked at $49K in Q3 2019.
136 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2019.

Based on AJO LP's 13F filing for Q4 2019, filed 12 Feb 2020.